688317.SH
之江生物
SSE · Healthcare · Biotechnology · CN
CNY 17.17
−2.99%Margins
Gross margin
65.1%
EBITDA margin
15.0%
EBIT margin
-47.6%
Net margin
-37.1%
FCF margin
33.2%
-1.3%
Return on equity
-1.2%
Return on assets
-1.6%
Return on invested capital
0.03x
Asset turnover
CNY 61.2M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026